Home/Filings/4/0001549595-25-000035
4//SEC Filing

SANDS ARTHUR T 4

Accession 0001549595-25-000035

CIK 0001549595other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:12 PM ET

Size

5.4 KB

Accession

0001549595-25-000035

Insider Transaction Report

Form 4
Period: 2025-02-11
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-02-11+450,000450,000 total
    Exercise: $17.12Exp: 2035-02-10Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/36 of the total shares monthly beginning March 11, 2025, until the option is fully vested on February 10, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001134106

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:12 PM ET
Size
5.4 KB